Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines
Delivery carriers are a critical component in the development of mRNA vaccines. Here, we describe the synthesis of a cationic polymer as a carrier for mRNA cancer vaccine delivery. In vivo results show that this polymer-based mRNA vaccine significantly delays tumor growth after vaccination of mice.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743697/
Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccine-CEJ 2023 Jan
Related Content
Protein kinase N3 (PKN3) is a serine/threonine kinase implicated in tumor progression across multiple cancer types. PKN3 mRNA is almost undetectable in normal adult...
VIEW RESOURCEDespite the excellent clinical response to paclitaxel therapy, drug resistance inevitably develops in subsequent treatments. The mechanisms for resistance to...
VIEW RESOURCE